We are live on ! Find out more
ITCI icon

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

1 hedge funds and large institutions have $2.54K invested in Intra-Cellular Therapies Inc. in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $2.54K → $2.54K ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ITCI Hedge Fund Activity: Q2 2026 in Review

1 of the 8,351 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2026, worth a combined $2.54K — unchanged from a quarter earlier.

Fund positioning in ITCI was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $2.54K of Intra-Cellular Therapies Inc. stock for Q2 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2026 and 0 closed out.

Based on aggregated 13F filings for Q2 2026.